Physician

Marie E. Matty, M.D.

According to 2025 Medicare claims, Marie Matty, M.D. (NPI: 1740224880) practices family practice in the Bremerton-Silverdale-Port Orchard, WA market, with the plurality of this provider's patient population coming from Kitsap, WA. This provider's primary affiliated billing organization is CHYMIYMATTYMD LLC (NPI: 1982073235; TIN: 474836029) and primary practice location at 98370-9998. Matty is affiliated with the CommonSpirit ACO I (ACO ID: A2164) and Jefferson Accountable Care, LLC (ACO ID: A5275), participating under the MSSP model.

Matty's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 475 traditional Medicare patients, billed 5,152 HCPCS/CPT codes, and received $238,634 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,232 prescription claims across 182 beneficiaries totaling $265,809 in drug costs, led by Mounjaro (Tirzepatide). DME data shows 40 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $103,086 to $238,634. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $107,778 to $265,809. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $6,851 to $9,632.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	411	3,655	$103,086
2016	185	2,046	$92,575
2017	184	3,074	$113,467
2018	177	2,788	$105,989
2019	162	2,237	$103,699
2020	154	2,348	$105,124
2021	315	3,353	$136,527
2022	326	3,494	$171,832
2023	425	3,798	$182,897
2024	475	5,152	$238,634

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	229	2,335	$107,778
2016	174	1,997	$99,276
2017	133	1,987	$100,852
2018	133	2,048	$127,399
2019	123	2,103	$153,159
2020	113	2,248	$185,463
2021	129	2,325	$231,581
2022	171	2,599	$242,357
2023	164	2,771	$232,943
2024	182	3,232	$265,809

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	138	$8,117
2016	N/R	47	$1,798
2017	N/R	33	$382
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	61	$1,859
2021	N/R	76	$2,785
2022	N/R	34	$1,065
2023	N/R	38	$3,269
2024	N/R	40	$4,397

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	134	339	$87
99490	Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month	215	2,194	$38
99211	Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional	94	110	$17
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	89	146	$12
36415	Insertion of needle into vein for collection of blood sample	325	474	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Mounjaro	Tirzepatide	32	1,016	$36,837
Jardiance	Empagliflozin	29	1,650	$31,562
Ozempic	Semaglutide	25	764	$24,708
Xarelto	Rivaroxaban	22	1,200	$21,949
Farxiga	Dapagliflozin Propanediol	19	966	$17,228

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	12	$3,712
E0601	Continuous positive airway pressure (cpap) device	Y	N/R	16	$575
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	N	N/R	12	$110

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Marie E. Matty, M.D.?

Tedicare shows public-source Medicare data for Marie E. Matty, M.D. (NPI 1740224880), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Marie E. Matty, M.D. have ACO affiliation data?

Marie E. Matty, M.D. is shown with ACO affiliation data for CommonSpirit ACO I (MSSP, ACO ID A2164) and Jefferson Accountable Care, LLC (MSSP, ACO ID A5275).

What billing organization is linked to Marie E. Matty, M.D.?

Marie E. Matty, M.D. is linked to CHYMIYMATTYMD LLC (billing NPI 1982073235) in the available physician profile data.

Does Marie E. Matty, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.